Overview
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
Similar content being viewed by others
Keywords
Table of contents (8 chapters)
Reviews
'All health organisations and jurisdictions through-out the world are faced with the challenge of how to fund an increasingly complex health system. Whether the issue is how to decide on which new treatment should be made available to whom in a well developed health system or to decide on what basic prophylactic or pharmacologic intervention can be afforded in a
transitional country. Choices are often difficult and complex. This new text develops a pragmatic approach to this problem using the case study of pharmaceuticals and applying the key principles of moral philosophy and welfare economics.' - Ian Rouse, Professor and Executive Dean, Faculty of Health Engineering and Science, Victoria University, Australia
With a Foreword from Professor Elizabeth Harman, Vice - Chancellor, Victoria University, Australia
Authors and Affiliations
About the authors
CHRISTINE MAK is a Research Scholar at the Centre for Strategic Studies, Victoria University, Australia, who has extensive publishing experience in the field of welfare economics.
Bibliographic Information
Book Title: Normative Health Economics
Book Subtitle: A New Pragmatic Approach to Cost Benefit Analysis, Mathematical Models and Applications
Authors: Sardar M. N. Islam, Christine Suet Yee Mak
DOI: https://doi.org/10.1057/9780230289055
Publisher: Palgrave Macmillan London
eBook Packages: Palgrave Economics & Finance Collection, Economics and Finance (R0)
Copyright Information: Palgrave Macmillan, a division of Macmillan Publishers Limited 2006
Hardcover ISBN: 978-1-4039-8749-5Published: 06 December 2006
eBook ISBN: 978-0-230-28905-5Published: 06 December 2006
Edition Number: 1
Number of Pages: XXVI, 345
Topics: Social Choice/Welfare Economics/Public Choice/Political Economy, Microeconomics, Medicine/Public Health, general, Macroeconomics/Monetary Economics//Financial Economics, Health Economics